PsyBio Therapeutics Institutionelles Eigentum

Was ist das Institutionelles Eigentum von PsyBio Therapeutics?

Institutionelles Eigentum von PsyBio Therapeutics Corp. ist 13.39%

Was ist die Definition von Institutionelles Eigentum?

Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Was macht PsyBio Therapeutics?

PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.

Unternehmen mit institutionelles eigentum ähnlich PsyBio Therapeutics